Found 19 matching trials
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis PHASE3 This study was conducted to explore a new therapy for anemia in participant...
Show More Learn More & Join Trial
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) PHASE2 Daprodustat administration has the potential, by virtue of increasing hypox...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome PHASE3 Erythropoietin (EPO) treatment in patients with the severe cardiorenal synd...
Show More Location
Meander Medical Center Amersfoort
Learn More & Join Trial
Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants PHASE3 The purpose of this study is to assess the safety and effectiveness of roxa...
Show More Learn More & Join Trial
A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia PHASE3 This 2 arm study will compare the efficacy and safety of monthly administra...
Show More Location
Multiple Locations
Learn More & Join Trial
A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients NA This is a prospective single-arm open-labeled cohort study on dialysis pati...
Show More Location
Division of Nephrology, Department of Medicine, Queen Mary Hospital
Learn More & Join Trial
Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis PHASE2 The primary objective of this study is to evaluate the efficacy and safety ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia PHASE2 The primary purpose of this study is to evaluate efficacy and safety of rox...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants PHASE3 The purpose of this study is to assess the safety and effectiveness of Roxa...
Show More Location
Investigational Site
Learn More & Join Trial
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy PHASE3 To assess the change in hemoglobin levels when iron sucrose was added to a ...
Show More Location
Multiple Locations
Learn More & Join Trial